PhytoHealth Corporation (4108.TW)

TWD 15.95

(-0.31%)

Inventory Summary of PhytoHealth Corporation

  • PhytoHealth Corporation's latest annual inventory in 2023 was 163.09 Million TWD , up 7.85% from previous year.
  • PhytoHealth Corporation's latest quarterly inventory in 2024 Q2 was 160.96 Million TWD , up 6.17% from previous quarter.
  • PhytoHealth Corporation reported annual inventory of 151.22 Million TWD in 2022, up 3.85% from previous year.
  • PhytoHealth Corporation reported annual inventory of 145.62 Million TWD in 2021, down -3.91% from previous year.
  • PhytoHealth Corporation reported quarterly inventory of 160.96 Million TWD for 2024 Q2, up 6.17% from previous quarter.
  • PhytoHealth Corporation reported quarterly inventory of 180.03 Million TWD for 2023 Q3, up 6.79% from previous quarter.

Annual Inventory Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual Inventory of PhytoHealth Corporation (2023 - 2009)

Year Inventory Inventory Growth
2023 163.09 Million TWD 7.85%
2022 151.22 Million TWD 3.85%
2021 145.62 Million TWD -3.91%
2020 151.55 Million TWD 23.66%
2019 122.55 Million TWD 26.16%
2018 97.14 Million TWD 9.85%
2017 88.43 Million TWD 21.9%
2016 72.54 Million TWD 23.93%
2015 58.53 Million TWD 43.37%
2014 40.82 Million TWD -57.32%
2013 95.65 Million TWD 70.02%
2012 56.26 Million TWD 1677.04%
2011 3.16 Million TWD -42.91%
2010 5.54 Million TWD 606.5%
2009 785 Thousand TWD 0.0%

Peer Inventory Comparison of PhytoHealth Corporation

Name Inventory Inventory Difference
Grape King Bio Ltd 737.18 Million TWD 77.877%
Standard Chem & Pharm CO., LTD. 1.61 Billion TWD 89.901%
Maywufa Company Ltd. 257.91 Million TWD 36.765%
ScinoPharm Taiwan, Ltd. 1.51 Billion TWD 89.21%
Lotus Pharmaceutical Co., Ltd. 3.77 Billion TWD 95.68%
LIWANLI Innovation Co., Ltd. 60.81 Million TWD -168.156%
YungShin Global Holding Corporation 2.77 Billion TWD 94.119%
SCI Pharmtech, Inc. 529.53 Million TWD 69.201%
Formosa Laboratories, Inc. 1.59 Billion TWD 89.791%
PharmaEssentia Corporation 1.45 Billion TWD 88.819%
Bora Pharmaceuticals Co., LTD. 2.15 Billion TWD 92.436%